Pharma Journalist -

Abbott announced that m-PIMA HIV-1/2 VL, the world's first point-of-care viral load diagnostic test, has received the World Health Organization's Prequalification approval (WHO PQ). The…
Read More...

Glenmark Therapeutics Inc., USA, a wholly-owned subsidiary of Glenmark Holding SA., announced a co-promotion agreement with Otonomy, a biopharmaceutical company dedicated to the…
Read More...

Exelixis, Inc. announced that it is initiating COSMIC-313, a phase 3 pivotal trial of cabozantinib (CABOMETYX) in combination with nivolumab (Opdivo) and ipilimumab (Yervoy) versus…
Read More...

The U.S. Food and Drug Administration announced the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3…
Read More...

CStone Pharmaceuticals and Numab Therapeutics AG announce that they have entered into an exclusive regional licensing agreement for the development and commercialization of ND021, a…
Read More...

Tmunity Therapeutics announced that it has entered into an exclusive licensing and research collaboration with the University of California San Francisco (UCSF) aimed at advancing novel…
Read More...

SMi reports: There are two post-conference workshops taking place on the 5th June 2019, which will explain lyophilisation in its most simplistic terms. SMi’s 7th annual…
Read More...

PolyProx Therapeutics, a new biotechnology company focused on the discovery and development of novel biopharmaceuticals for the treatment of cancer, announced that it has raised £3.4m…
Read More...

AstraZeneca and BenevolentAI began a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treatments for chronic…
Read More...

Sandoz, a Novartis division and a global leader in biosimilars, announced that it has entered into an agreement to commercialize a proposed trastuzumab biosimilar. This medicine is…
Read More...